As of 2024-12-15, the Relative Valuation of Alligator Bioscience AB (ATORX.ST) is (6.79) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.28 SEK, the upside of Alligator Bioscience AB based on Relative Valuation is -2490.4%.
The range of the Relative Valuation is (5.21) - (7.94) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 27.7x | 21.8x |
| Forward P/E multiples | 15.1x - 24.2x | 19.6x |
| Fair Price | (5.21) - (7.94) | (6.79) |
| Upside | -1936.2% - -2895.8% | -2490.4% |
| Date | P/E |
| 2024-12-11 | -0.90 |
| 2024-12-10 | -0.94 |
| 2024-12-09 | -0.74 |
| 2024-12-06 | -0.75 |
| 2024-12-05 | -0.75 |
| 2024-12-04 | -0.69 |
| 2024-12-03 | -0.76 |
| 2024-12-02 | -0.82 |
| 2024-11-29 | -1.70 |
| 2024-11-28 | -1.67 |
| 2024-11-27 | -1.64 |
| 2024-11-26 | -1.58 |
| 2024-11-25 | -1.63 |
| 2024-11-22 | -1.61 |
| 2024-11-21 | -1.69 |
| 2024-11-20 | -1.54 |
| 2024-11-19 | -1.77 |
| 2024-11-18 | -1.87 |
| 2024-11-15 | -2.02 |
| 2024-11-14 | -2.07 |
| 2024-11-13 | -2.11 |
| 2024-11-12 | -2.07 |
| 2024-11-11 | -2.11 |
| 2024-11-08 | -2.12 |
| 2024-11-07 | -2.20 |
| 2024-11-06 | -2.02 |
| 2024-11-05 | -2.20 |
| 2024-11-04 | -2.14 |
| 2024-11-01 | -2.24 |
| 2024-10-31 | -2.36 |
| 2024-10-30 | -2.49 |
| 2024-10-29 | -2.53 |
| 2024-10-28 | -2.24 |
| 2024-10-25 | -2.14 |
| 2024-10-24 | -2.60 |
| 2024-10-23 | -3.57 |
| 2024-10-22 | -3.63 |
| 2024-10-21 | -3.69 |
| 2024-10-18 | -3.85 |
| 2024-10-17 | -3.85 |
| 2024-10-16 | -3.79 |
| 2024-10-15 | -3.91 |
| 2024-10-14 | -3.91 |
| 2024-10-11 | -3.99 |
| 2024-10-10 | -4.02 |
| 2024-10-09 | -4.08 |
| 2024-10-08 | -4.03 |
| 2024-10-07 | -3.99 |
| 2024-10-04 | -4.00 |
| 2024-10-03 | -3.97 |